107 related articles for article (PubMed ID: 3040566)
21. Survival in breast cancer related to tumour oestrogen receptor status and immunohistochemical staining for NCRC 11.
Angus B; Napier J; Purvis J; Ellis IO; Hawkins RA; Carpenter F; Horne CH
J Pathol; 1986 Aug; 149(4):301-6. PubMed ID: 3020217
[TBL] [Abstract][Full Text] [Related]
22. [Inflammatory breast cancers: correlation between anatomopathology and steroid receptor assay].
Mauriac L; Wafflart J; Trojani M; Durand M
Bull Cancer; 1983; 70(3):160-4. PubMed ID: 6309290
[TBL] [Abstract][Full Text] [Related]
23. Quantitation of estrogen receptor content and Ki-67 staining in breast carcinoma by the microTICAS image analysis system.
Franklin WA; Bibbo M; Doria MI; Dytch HE; Toth J; DeSombre E; Wied GL
Anal Quant Cytol Histol; 1987 Aug; 9(4):279-86. PubMed ID: 2822057
[TBL] [Abstract][Full Text] [Related]
24. [Nuclear morphometry and estrogen receptors in infiltrating ductal carcinoma of the breast].
Giardina C; Serio G; Simone G; Pennella A; Vacca E; Ricco R; Scordari D; Pesce Delfino V
Boll Soc Ital Biol Sper; 1990 Feb; 66(2):135-41. PubMed ID: 2162679
[TBL] [Abstract][Full Text] [Related]
25. Relation of elastosis to biochemical and immunohistochemical steroid receptor findings, Ki-67 and epidermal growth factor receptor (EGFR) immunostaining in invasive ductal breast cancer.
Remmele W; Dietz M; Schmidt F; Schicketanz KH
Virchows Arch A Pathol Anat Histopathol; 1993; 422(4):319-26. PubMed ID: 8389501
[TBL] [Abstract][Full Text] [Related]
26. [Monoclonal antibodies for the immunohistochemical detection of estrogen receptor status in tissue sections of primary breast cancers].
Beck T; Pollow K; Heubner A
Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):490-4. PubMed ID: 3530871
[TBL] [Abstract][Full Text] [Related]
27. Mean nuclear area and metallothionein expression in ductal breast tumors: correlation with estrogen receptor status.
El Sharkawy SL; Farrag AR
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):108-12. PubMed ID: 18227734
[TBL] [Abstract][Full Text] [Related]
28. Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy.
Henry JA; Nicholson S; Hennessy C; Lennard TW; May FE; Westley BR
Br J Cancer; 1990 Jan; 61(1):32-8. PubMed ID: 2153395
[TBL] [Abstract][Full Text] [Related]
29. Oestrogen receptor assay of cryostat sections of human breast carcinomas with simultaneous quantitative histology.
Underwood JC; Dangerfield VJ; Parsons MA
J Clin Pathol; 1983 Apr; 36(4):399-405. PubMed ID: 6833509
[TBL] [Abstract][Full Text] [Related]
30. [Estrogen receptor status in breast carcinoma. Results of comparative immunohistochemical and biochemical studies].
Köhler G; Bässler R
Dtsch Med Wochenschr; 1986 Dec; 111(51-52):1954-60. PubMed ID: 3024947
[TBL] [Abstract][Full Text] [Related]
31. Correlation of an estrogen receptor-related phosphoprotein with histopathological features in breast cancer.
Tomasino RM; Daniele E; Nuara R; Morello V; Salvato M; Florena AM
Int J Biol Markers; 1989; 4(2):95-102. PubMed ID: 2549126
[TBL] [Abstract][Full Text] [Related]
32. Measurement of oestrogen receptor mRNA levels in human breast tumours.
Henry JA; Nicholson S; Farndon JR; Westley BR; May FE
Br J Cancer; 1988 Nov; 58(5):600-5. PubMed ID: 2851309
[TBL] [Abstract][Full Text] [Related]
33. Quantitation of the immunocytochemical assay for estrogen receptor protein (ER-ICA) in human breast cancer by television imaging.
Sklarew RJ; Pertschuk LP
J Histochem Cytochem; 1987 Nov; 35(11):1253-9. PubMed ID: 2821106
[TBL] [Abstract][Full Text] [Related]
34. Histochemical studies of human breast cancer using a monoclonal antibody against an oestrogen receptor-related antigen.
Hawkins RA; Sangster K; Krajewski A
Br J Cancer; 1987 Jun; 55(6):611-6. PubMed ID: 3620302
[TBL] [Abstract][Full Text] [Related]
35. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
[TBL] [Abstract][Full Text] [Related]
36. [Morphometric correlates of the steroid receptor content in invasive ductal breast cancers].
Mattfeldt T; Neurohr W; Müller A; Klinga K
Verh Dtsch Ges Pathol; 1985; 69():350-5. PubMed ID: 3006385
[No Abstract] [Full Text] [Related]
37. Comparison between a biochemical and a histochemical method for the detection of oestrogen receptor in breast carcinoma.
McMahon RT; Connolly CE
Ir J Med Sci; 1985 May; 154(5):187-92. PubMed ID: 2993194
[No Abstract] [Full Text] [Related]
38. Correlation between morphometrical parameters and disease-free survival in ductal breast cancer treated only by surgery.
Tosi P; Luzi P; Sforza V; Santopietro R; Bindi M; Tucci E; Barbini P; Baak JP
Appl Pathol; 1986; 4(1-2):33-42. PubMed ID: 3034310
[TBL] [Abstract][Full Text] [Related]
39. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
Reiner A; Neumeister B; Reiner G; Jakesz R; Kolb R; Schemper M; Spona J
Zentralbl Pathol; 1991; 137(3):233-41. PubMed ID: 1657132
[TBL] [Abstract][Full Text] [Related]
40. Relationships between oestrogen receptor,epidermal growth factor receptor, ER-D5, and P24 oestrogen regulated protein in human breast cancer.
Horne GM; Angus B; Wright C; Needham G; Nicholson S; Harris AL; Innes B; Horne CH
J Pathol; 1988 Jun; 155(2):143-50. PubMed ID: 3292735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
